Production (Stage)
Enzo Biochem, Inc.
ENZB
$0.6801
-$0.001-0.15%
OTC PK
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -12.71% | 18.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.71% | 18.04% | |||
| Cost of Revenue | 10.40% | -9.76% | |||
| Gross Profit | -34.37% | 66.01% | |||
| SG&A Expenses | 9.39% | -8.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.57% | -9.14% | |||
| Operating Income | -111.55% | 55.77% | |||
| Income Before Tax | -90.22% | 59.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -90.22% | 59.36% | |||
| Earnings from Discontinued Operations | -44.95% | 5.90% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -81.76% | 54.53% | |||
| EBIT | -111.55% | 55.77% | |||
| EBITDA | -139.17% | 61.13% | |||
| EPS Basic | -80.95% | 54.49% | |||
| Normalized Basic EPS | -89.93% | 59.40% | |||
| EPS Diluted | -80.95% | 58.00% | |||
| Normalized Diluted EPS | -89.93% | 59.40% | |||
| Average Basic Shares Outstanding | 0.20% | 0.10% | |||
| Average Diluted Shares Outstanding | 0.20% | 0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 1.00% | -- | |||